Clicky

Century Therapeutics, Inc.(IPSC)

Description: Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provides an opportunity to advance the course of cancer care.


Keywords: Biotechnology Cancer Life Sciences Biology Stem Cell Cell Therapy Cell Biology Cloning Induced Stem Cells Cancer Care

Home Page: www.centurytx.com

IPSC Technical Analysis

3675 Market Street
Philadelphia, PA 19104
United States
Phone: 267 817 5790


Officers

Name Title
Dr. Osvaldo Flores Ph.D. Pres, CEO & Director
Dr. Adrienne Farid Ph.D. Chief Operations Officer
Dr. Luis Borges Chief Scientific Officer
Mr. Douglas Carr CPA VP of Fin. and Operations & Sec.
Dr. Gregory Russotti Ph.D. Chief Technology Officer
Mr. Kenneth J. Dow J.D. Head of Legal & Compliance
Dr. Shane Williams Ph.D. Chief People Officer
Dr. Michael C. Diem Chief Bus. Officer
Dr. Hyam I. Levitsky M.D. Pres of R&D
Mr. Mark Wallet Head of Immunology & VP

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 47.8
Price-to-Book MRQ: 1.5109
Price-to-Sales TTM: 102.4926
IPO Date: 2021-06-18
Fiscal Year End: December
Full Time Employees: 170
Back to stocks